Immune Repertoire Sequencing Market : Table of Content


  • Published On : Oct-2018 |
  • Pages : 219 Pages |
  • Format : Immune Repertoire Sequencing Market Immune Repertoire Sequencing Market Immune Repertoire Sequencing Market Immune Repertoire Sequencing Market


1. Executive Summary
   1.1. Market Overview
   1.2. Market Analysis
   1.3. PMR Analysis and Recommendations
   1.4. Wheel of Fortune

2. Market Introduction
   2.1. Market Definition
   2.2. Market Taxonomy

3. Immune Repertoire Sequencing Market Opportunity Analysis
   3.1. Macro-Economic Factors
   3.2. Opportunity Analysis

4. Market Background
   4.1. Market Dynamics
        4.1.1. Drivers
        4.1.2. Restraints
        4.1.3. Opportunity
        4.1.4. Trends

5. Global Economic Outlook
   5.1. Gross Domestic Product by Region & Country, 2006 – 2021
   5.2. Global Healthcare Market Outlook

6. Key Inclusions
   6.1. Product Mapping
   6.2. Key Developments
   6.3. Regional Average Pricing Analysis (2017)

7. North America Immune Repertoire Sequencing Market Analysis 2013–2017 and Forecast 2018–2026
   7.1. Introduction
   7.2. Historical Market Value (US$ Mn) Trend Analysis By Country, 2013–2017
        7.2.1. U.S.
        7.2.2. Canada
   7.3. Market Value (US$ Mn) Forecast By Country, 2018–2026
   7.4. Historical Market Value (US$ Mn) and By Component, 2012-2016
        7.4.1. Assay Kits
               7.4.1.1. TCR Kits
               7.4.1.2. BCR Kits
        7.4.2. Software & Services
               7.4.2.1. Analytical Software
               7.4.2.2. Sequencing Services
               7.4.2.3. Data Analysis Services
   7.5. Market Value (US$ Mn) and Forecast By Component, 2018-2026
   7.6. Historical Market Value(US$ Mn) By Application, 2012-2016
        7.6.1. Biomarker Discovery
        7.6.2. Infectious Diseases
        7.6.3. Vaccine Development and efficacy
        7.6.4. Cancer Immunotherapy
        7.6.5. Autoimmune Disease
        7.6.6. Transplant Rejection and Tolerance
        7.6.7. Others
   7.7. Market Value (US$ Mn) Forecast By Application, 2018-2026
   7.8. Historical Market Value (US$ Mn) By End user, 2012-2016
        7.8.1. Academic Institutes
        7.8.2. Research Centers
   7.9. Market Value (US$ Mn) Forecast By End user,2018-2026
   7.10. Market Attractiveness Analysis
        7.10.1. By Country
        7.10.2. By Component
        7.10.3. By Application
        7.10.4. By End user
   7.11. Drivers and Restraints: Impact Analysis

8. Latin America Immune Repertoire Sequencing Market Analysis 2013–2017 and Forecast 2018–2026
   8.1. Introduction
   8.2. Key Regulations
   8.3. Regional Market Dynamics
        8.3.1. Drivers
        8.3.2. Restraints
        8.3.3. Trends
   8.4. Historical Market Size (US$ Mn) and By Country, 2012-2016
        8.4.1. Brazil
        8.4.2. Mexico
        8.4.3. Rest of Latin America
   8.5. Market Size (US$ Mn) and Forecast By Country, 2018-2026
   8.6. Historical Market Value (US$ Mn) and By Component, 2012-2016
        8.6.1. Assay Kits
               8.6.1.1. TCR Kits
               8.6.1.2. BCR Kits
        8.6.2. Software & Services
               8.6.2.1. Analytical Software
               8.6.2.2. Sequencing Services
               8.6.2.3. Data Analysis Services
   8.7. Market Value (US$ Mn) and Forecast By Component, 2018-2026
   8.8. Historical Market Value (US$ Mn) By Application, 2012-2016
        8.8.1. Biomarker Discovery
        8.8.2. Infectious Diseases
        8.8.3. Vaccine Development and efficacy
        8.8.4. Cancer Immunotherapy
        8.8.5. Autoimmune Disease
        8.8.6. Transplant Rejection and Tolerance
        8.8.7. Others
   8.9. Market Value (US$ Mn) Forecast By Application, 2018-2026
   8.10. Historical Market Value (US$ Mn) By End user, 2012-2016
        8.10.1. Academic Institutes
        8.10.2. Research Centers
   8.11. Market Value (US$ Mn) Forecast By End user, 2018-2026
   8.12. Market Attractiveness Analysis
        8.12.1. By Country
        8.12.2. By Component
        8.12.3. By Application
        8.12.4. By End user
   8.13. Drivers and Restraints: Impact Analysis

9. Europe Immune Repertoire Sequencing Market Analysis 2013–2017 and Forecast 2018–2026
   9.1. Introduction
   9.2. Key Regulations
   9.3. Regional Market Dynamics
        9.3.1. Drivers
        9.3.2. Restraints
        9.3.3. Trends
   9.4. Historical Market Size (US$ Mn) and By Country, 2012-2016
        9.4.1. Germany
        9.4.2. U.K.
        9.4.3. France
        9.4.4. Italy
        9.4.5. Spain
        9.4.6. Poland
        9.4.7. Russia
        9.4.8. Rest of Europe
   9.5. Market Size (US$ Mn) and Forecast By Country, 2018-2026
   9.6. Historical Market Value (US$ Mn) and By Component, 2012-2016
        9.6.1. Assay Kits
               9.6.1.1. TCR Kits
               9.6.1.2. BCR Kits
        9.6.2. Software & Services
               9.6.2.1. Analytical Software
               9.6.2.2. Sequencing Services
               9.6.2.3. Data Analysis Services
   9.7. Market Value (US$ Mn) and Forecast By Component, 2018-2026
   9.8. Historical Market Value(US$ Mn) By Application, 2012-2016
        9.8.1. Biomarker Discovery
        9.8.2. Infectious Diseases
        9.8.3. Vaccine Development and efficacy
        9.8.4. Cancer Immunotherapy
        9.8.5. Autoimmune Disease
        9.8.6. Transplant Rejection and Tolerance
        9.8.7. Others
   9.9. Market Value (US$ Mn) Forecast By Application, 2018-2026
   9.10. Historical Market Value (US$ Mn) By End user, 2012-2016
        9.10.1. Academic Institutes
        9.10.2. Research Centers
   9.11. Market Value (US$ Mn) Forecast By End user, 2018-2026
   9.12. Market Attractiveness Analysis
        9.12.1. By Country
        9.12.2. By Component
        9.12.3. By Application
        9.12.4. By End user
   9.13. Drivers and Restraints: Impact Analysis

10. Asia Pacific (APAC) Immune Repertoire Sequencing Market Analysis 2013–2017 and Forecast 2018–2026
   10.1. Introduction
   10.2. Key Regulations
   10.3. Regional Market Dynamics
        10.3.1. Drivers
        10.3.2. Restraints
        10.3.3. Trends
   10.4. Historical Market Size (US$ Mn) and By Country, 2012-2016
        10.4.1. China
        10.4.2. India
        10.4.3. Japan
        10.4.4. Australia and New Zealand
        10.4.5. Rest of APAC
   10.5. Market Size (US$ Mn) and Forecast By Country, 2018-2026
   10.6. Historical Market Value (US$ Mn) and By Component, 2012-2016
        10.6.1. Assay Kits
               10.6.1.1. TCR Kits
               10.6.1.2. BCR Kits
        10.6.2. Software & Services
               10.6.2.1. Analytical Software
               10.6.2.2. Sequencing Services
               10.6.2.3. Data Analysis Services
   10.7. Market Value (US$ Mn) and Forecast By Component, 2018-2026
   10.8. Historical Market Value (US$ Mn) By Application, 2012-2016
        10.8.1. Biomarker Discovery
        10.8.2. Infectious Diseases
        10.8.3. Vaccine Development and efficacy
        10.8.4. Cancer Immunotherapy
        10.8.5. Autoimmune Disease
        10.8.6. Transplant Rejection and Tolerance
        10.8.7. Others
   10.9. Market Value (US$ Mn) Forecast By Application, 2018-2026
   10.10. Historical Market Value (US$ Mn) By End user, 2012-2016
        10.10.1. Academic Institutes
        10.10.2. Research Centers
   10.11. Market Value (US$ Mn) Forecast By End user,2018-2026
   10.12. Market Attractiveness Analysis
        10.12.1. By Country
        10.12.2. By Component
        10.12.3. By Application
        10.12.4. By End user
   10.13. Drivers and Restraints: Impact Analysis

11. Middle East and Africa (MEA) Immune Repertoire Sequencing Market Analysis 2013–2017 and Forecast 2018–2026
   11.1. Introduction
   11.2. Key Regulations
   11.3. Regional Market Dynamics
        11.3.1. Drivers
        11.3.2. Restraints
        11.3.3. Trends
   11.4. Historical Market Size (US$ Mn) and By Country, 2012-2016
        11.4.1. GCC Countries
        11.4.2. South Africa
        11.4.3. Rest of MEA
   11.5. Market Size (US$ Mn) and Forecast By Country, 2018-2026
   11.6. Historical Market Value (US$ Mn) and By Component, 2012-2016
        11.6.1. Assay Kits
               11.6.1.1. TCR Kits
               11.6.1.2. BCR Kits
        11.6.2. Software & Services
               11.6.2.1. Analytical Software
               11.6.2.2. Sequencing Services
               11.6.2.3. Data Analysis Services
   11.7. Market Value (US$ Mn) and Forecast By Component, 2018-2026
   11.8. Historical Market Value(US$ Mn) By Application, 2012-2016
        11.8.1. Biomarker Discovery
        11.8.2. Infectious Diseases
        11.8.3. Vaccine Development and efficacy
        11.8.4. Cancer Immunotherapy
        11.8.5. Autoimmune Disease
        11.8.6. Transplant Rejection and Tolerance
        11.8.7. Others
   11.9. Market Value (US$ Mn) Forecast By Application, 2018-2026
   11.10. Historical Market Value (US$ Mn) By End user, 2012-2016
        11.10.1. Academic Institutes
        11.10.2. Research Centers
   11.11. Market Value (US$ Mn) Forecast By End user,2018-2026
   11.12. Market Attractiveness Analysis
        11.12.1. By Country
        11.12.2. By Component
        11.12.3. By Application
        11.12.4. By End user
   11.13. Drivers and Restraints: Impact Analysis

12. Forecast Factors: Relevance and Impact

13. Market Structure Analysis
   13.1. Market Structure by Tier Companies

   13.2. Competition Dashboard
   13.3. Market Share Analysis (2017) by Global level

14. Competition Profile
   14.1. Company Deep Dive
        14.1.1. Illumina, Inc.
               14.1.1.1. Overview
               14.1.1.2. Key Financials
               14.1.1.3. Product and Application Portfolio
               14.1.1.4. Key Developments
               14.1.1.5. Strategy
                               14.1.1.5.1.1. Marketing Strategy
                               14.1.1.5.1.2. Product Strategy
                               14.1.1.5.1.3. Channel Strategy
        14.1.2. Pacific Biosciences of California, Inc
               14.1.2.1. Overview
               14.1.2.2. Key Financials
               14.1.2.3. Product and Application Portfolio
               14.1.2.4. Key Developments
               14.1.2.5. Strategy
                               14.1.2.5.1.1. Marketing Strategy
                               14.1.2.5.1.2. Product Strategy
                               14.1.2.5.1.3. Channel Strategy
        14.1.3. Agilent Technologies, Inc
               14.1.3.1. Overview
               14.1.3.2. Key Financials
               14.1.3.3. Product and Application Portfolio
               14.1.3.4. Key Developments
               14.1.3.5. Strategy
                               14.1.3.5.1.1. Marketing Strategy
                               14.1.3.5.1.2. Product Strategy
                               14.1.3.5.1.3. Channel Strategy
        14.1.4. Oxford Nanopore Technologies, Ltd
               14.1.4.1. Overview
               14.1.4.2. Product and Application Portfolio
               14.1.4.3. Key Developments
               14.1.4.4. Strategy
                               14.1.4.4.1.1. Marketing Strategy
                               14.1.4.4.1.2. Product Strategy
                               14.1.4.4.1.3. Channel Strategy
        14.1.5. QIAGEN N.V.
               14.1.5.1. Overview
               14.1.5.2. Key Financials
               14.1.5.3. Product and Application Portfolio
               14.1.5.4. Key Developments
               14.1.5.5. Strategy
                               14.1.5.5.1.1. Marketing Strategy
                               14.1.5.5.1.2. Product Strategy
                               14.1.5.5.1.3. Channel Strategy
        14.1.6. Thermo Fisher Scientific
               14.1.6.1. Overview
               14.1.6.2. Key Financials
               14.1.6.3. Product and Application Portfolio
               14.1.6.4. Key Developments
               14.1.6.5. Strategy
                               14.1.6.5.1.1. Marketing Strategy
                               14.1.6.5.1.2. Product Strategy
                               14.1.6.5.1.3. Channel Strategy
        14.1.7. F. Hoffmann-La Roche Ltd
               14.1.7.1. Overview
               14.1.7.2. Key Financials
               14.1.7.3. Product and Application Portfolio
               14.1.7.4. Key Developments
               14.1.7.5. Strategy
                               14.1.7.5.1.1. Marketing Strategy
                               14.1.7.5.1.2. Product Strategy
                               14.1.7.5.1.3. Channel Strategy
                               14.1.7.5.1.4. Channel Strategy
        14.1.8. BGI
               14.1.8.1. Overview
               14.1.8.2. Product and Application Portfolio
               14.1.8.3. Key Developments
               14.1.8.4. Strategy
                               14.1.8.4.1.1. Marketing Strategy
                               14.1.8.4.1.2. Product Strategy
                               14.1.8.4.1.3. Channel Strategy
                               14.1.8.4.1.4. Channel Strategy
        14.1.9. Takara Bio, Inc
               14.1.9.1. Overview
               14.1.9.2. Key Financials
               14.1.9.3. Product and Application Portfolio
               14.1.9.4. Key Developments
               14.1.9.5. Strategy
                               14.1.9.5.1.1. Marketing Strategy
                               14.1.9.5.1.2. Product Strategy
                               14.1.9.5.1.3. Channel Strategy
                               14.1.9.5.1.4. Channel Strategy

15. Global Immune Repertoire Sequencing Market Analysis 2013–2017 and Forecast 2018–2026, By Region
   15.1. Introduction
        15.1.1. Basis Point Share (BPS) Analysis By Region
        15.1.2. Y-o-Y Growth Projections By Region
   15.2. Historical Market Value Analysis 2013–2017, By Region
        15.2.1. North America
        15.2.2. Latin America
        15.2.3. Europe
        15.2.4. Asia Pacific (APAC)
        15.2.5. Middle East and Africa (MEA)
   15.3. Market Value Analysis 2018–2026, By Region
        15.3.1. North America
        15.3.2. Latin America
        15.3.3. Europe
        15.3.4. Asia Pacific (APAC)
        15.3.5. Middle East and Africa (MEA)
   15.4. Market Attractiveness Analysis By Region

16. Global Immune Repertoire Sequencing Market Analysis 2013–2017 and Forecast 2018–2026, By Component
   16.1. Introduction
        16.1.1. Basis Point Share (BPS) Analysis By Component
        16.1.2. Y-o-Y Growth Projections By Component
   16.2. Historical Market Value Analysis 2013–2017, By Component
        16.2.1. Assay Kits
               16.2.1.1. TCR Kits
               16.2.1.2. BCR Kits
        16.2.2. Software & Services
               16.2.2.1. Analytical Software
               16.2.2.2. Sequencing Services
               16.2.2.3. Data Analysis Services
   16.3. Market Value Analysis 2017–2015, By Component
   16.4. Market Attractiveness Analysis By Component

17. Global Immune Repertoire Sequencing Market Analysis 2013–2017 and Forecast 2018–2026, By Applications
   17.1. Introduction
        17.1.1. Basis Point Share (BPS) Analysis By Applications
        17.1.2. Y-o-Y Growth Projections By Applications
   17.2. Historical Market Value Analysis 2013–2017, By Applications
        17.2.1. Biomarker Discovery
        17.2.2. Infectious Diseases
        17.2.3. Vaccine Development and efficacy
        17.2.4. Cancer Immunotherapy
        17.2.5. Autoimmune Disease
        17.2.6. Transplant Rejection and Tolerance
        17.2.7. Others
   17.3. Historical Market Value Analysis 2018–2026, By Applications
   17.4. Market Attractiveness Analysis By Applications

18. Global Immune Repertoire Sequencing Market Analysis 2013–2017 and Forecast 2018–2026, By End User
   18.1. Introduction
        18.1.1. Basis Point Share (BPS) Analysis By End User
        18.1.2. Y-o-Y Growth Projections By End User
   18.2. Historical Market Value Analysis 2013–2017, By End User
        18.2.1. Academic Institutes
        18.2.2. Research Centers
   18.3. Market Value Analysis 2018–2026, By End User
   18.4. Market Attractiveness Analysis By End User

19. Global Immune Repertoire Sequencing Market Analysis 2013–2017 and Forecast 2017–2026
   19.1. Market Size and Y-o-Y Growth
   19.2. Absolute $ Opportunity

20. Assumptions and Acronyms Used

21. Research Methodology


List of Tables

Table 01: Expenditure on Health, (% of GDP), by Country, 2016 - 2021
Table 02: Expenditure on Health, (% of GDP), by Country, 2016 - 2021
Table 03: Assay Kits Product Mapping
Table 04: Assay Kits Product Mapping
Table 05: Software Services Product Mapping
Table 06: Software Services Product Mapping
Table 07: Software Services Product Mapping
Table 08: Software & Services Product Mapping
Table 09: Software & Services Product Mapping
Table 10: Key Developments
Table 11: Key Developments 
Table 12 : North America Immune Repertoire Sequencing Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
Table 13 : North America Immune Repertoire Sequencing Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Component
Table 14 : North America Immune Repertoire Sequencing Market Size Analysis 2013-2017 and Forecast 2018-2026, By Application
Table 15 : North America Immune Repertoire Sequencing Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By End User
Table 16 : Latin America Immune Repertoire Sequencing Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
Table 17 : Latin America Immune Repertoire Sequencing Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Component
Table 18 : Latin America Immune Repertoire Sequencing Market Size Analysis 2013-2017 and Forecast 2018-2026, By Application
Table 19 : Latin  America Immune Repertoire Sequencing Market Size Analysis 2013-2017 and Forecast 2018-2026, By End User
Table 20 : Europe Immune Repertoire Sequencing Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
Table 21 : Europe Immune Repertoire Sequencing Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Component
Table 22 : Europe Immune Repertoire Sequencing Market Size Analysis 2013-2017 and Forecast 2018-2026, By Application
Table 23 : Europe Immune Repertoire Sequencing Market Size Analysis 2013-2017 and Forecast 2018-2026, By End User
Table 24 : Asia Pacific Immune Repertoire Sequencing Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
Table 25 : Asia Pacific Immune Repertoire Sequencing Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Component
Table 26 : Asia Pacific Immune Repertoire Sequencing Market Size Analysis 2013-2017 and Forecast 2018-2026, By Application
Table 27 : Asia Pacific Immune Repertoire Sequencing Market Size Analysis 2013-2017 and Forecast 2018-2026, By End User
Table 28 : Middle East & Africa Immune Repertoire Sequencing Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
Table 29 : Middle East & Africa Immune Repertoire Sequencing Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Component
Table 30 : Middle East & Africa Immune Repertoire Sequencing Market Size Analysis 2013-2017 and Forecast 2018-2026, By Application
Table 31 : Middle East & Africa Immune Repertoire Sequencing Market Size Analysis 2013-2017 and Forecast 2018-2026, By End User
Table 32 : Global Immune Repertoire Sequencing Market Size (US$ Mn) 2013–2017 and Forecast 2018-2026 By Region
Table 33 : Global  Market Size (US$ Mn) 2013–2017 and Forecast 2018-2026 By Component
Table 34 : Global  Market Size (US$ Mn) 2013–2017 and Forecast 2018-2026 By Application 
Table 35 : Global  Market Size (US$ Mn) 2013–2017 and Forecast 2018-2026 By End User


List of Figures 

Figure 01 : Global Healthcare Expenditure in US$ Tn (2013–2020)
Figure 02: Regional Average Pricing Analysis (US$) of Assay Kits (2017)
Figure 03: Regional Average Pricing Analysis (US$) of Assay Kits s  (2026)
Figure 04: Regional Average Pricing Analysis (US$) Software & Services (2017)
Figure 05: Regional Average Pricing Analysis (US$) Software & Services (2026)
Figure 6 : North America Immune Repertoire Sequencing Market Size (US$ Mn) Analysis, 2013–2017
Figure 7 : North America Immune Repertoire Sequencing Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 8 : U.S. Immune Repertoire Sequencing Market Size (US$ Mn) Analysis, 2013–2017
Figure 9 : U.S. Immune Repertoire Sequencing Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 10 : Canada Immune Repertoire Sequencing Market Size (US$ Mn) Analysis, 2013–2017
Figure 11 : Canada Immune Repertoire Sequencing Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 12 : Assay Kits Market Size (US$ Mn) Analysis, 2013–2017
Figure 13 : Assay Kits Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 14 : Software Service Market Size (US$ Mn) Analysis, 2013–2017
Figure 15 : Software Service Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 16 : North America Medical immune repertoire sequencing Detectors Market Attractiveness Analysis, By Component
Figure 17 : North America Medical immune repertoire sequencing Detectors Market Attractiveness Analysis, By Application
Figure 18 : North America Medical immune repertoire sequencing Detectors Market Attractiveness Analysis, By End User
Figure 19 : North America Medical immune repertoire sequencing Detectors Market Attractiveness Analysis, By Country
Figure 20 : Latin America Immune Repertoire Sequencing Market Size (US$ Mn) Analysis, 2013–2017
Figure 21 : Latin America Immune Repertoire Sequencing Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 22 : Brazil  Immune Repertoire Sequencing Market Size (US$ Mn) Analysis, 2013–2017
Figure 23 : Brazil Immune Repertoire Sequencing Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 24 : Mexico Immune Repertoire Sequencing Market Size (US$ Mn) Analysis, 2013–2017
Figure 25: Mexico Immune Repertoire Sequencing Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 26 : Rest of Latin America Immune Repertoire Sequencing Market Size (US$ Mn) Analysis, 2013–2017
Figure 27 : Rest of Latin America Immune Repertoire Sequencing Market Size (US$ Mn) Analysis, 2013–2017
Figure 28 :Latin America Medical immune repertoire sequencing Detectors Market Attractiveness Analysis, By Component
Figure 29 : Latin America Medical immune repertoire sequencing Detectors Market Attractiveness Analysis, By Application
Figure 30 : Latin America Medical immune repertoire sequencing Detectors Market Attractiveness Analysis, By End User
Figure 31 : Latin America Medical immune repertoire sequencing Detectors Market Attractiveness Analysis, By Country
Figure 32 : Europe Immune Repertoire Sequencing Market Size (US$ Mn) Analysis, 2013–2017
Figure 33 : Europe Immune Repertoire Sequencing Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 34 : Germany Immune Repertoire Sequencing Market Size (US$ Mn) Analysis, 2013–2017
Figure 35 : Germany Immune Repertoire Sequencing Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 36 : U.K Immune Repertoire Sequencing Market Size (US$ Mn) Analysis, 2013–2017
Figure 37 : U.K. Immune Repertoire Sequencing Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 38 : France  Immune Repertoire Sequencing Market Size (US$ Mn) Analysis, 2013–2017
Figure 39 : France Immune Repertoire Sequencing Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 40 : Spain Immune Repertoire Sequencing Market Size (US$ Mn) Analysis, 2013–2017
Figure 41 : Spain Immune Repertoire Sequencing Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 42 : Italy  Immune Repertoire Sequencing Market Size (US$ Mn) Analysis, 2013–2017
Figure 43 : Italy Immune Repertoire Sequencing Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 44 : Russia Immune Repertoire Sequencing Market Size (US$ Mn) Analysis, 2013–2017
Figure 45 :  Russia Repertoire Sequencing Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 46 : Poland  Immune Repertoire Sequencing Market Size (US$ Mn) Analysis, 2013–2017
Figure 47 : Poland Immune Repertoire Sequencing Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 48 : Rest of Europe Immune Repertoire Sequencing Market Size (US$ Mn) Analysis, 2013–2017
Figure 49 :  Rest of Europe Repertoire Sequencing Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 50 : Europe immune repertoire sequencing Detectors Market Attractiveness Analysis, By Component
Figure 51 : Europe immune repertoire sequencing Detectors Market Attractiveness Analysis, By Application
Figure 52 : Europe immune repertoire sequencing Detectors Market Attractiveness Analysis, By End User
Figure 53 : Europe immune repertoire sequencing Detectors Market Attractiveness Analysis, By Country
Figure 54 : Asia Pacific Immune Repertoire Sequencing Market Size (US$ Mn) Analysis, 2013–2017
Figure 55 : Asia Pacific Immune Repertoire Sequencing Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 56 : India Repertoire Sequencing Market Size (US$ Mn) Analysis, 2013–2017
Figure 57 : India Immune Repertoire Sequencing Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 58 : Aus & NZ  Immune Repertoire Sequencing Market Size (US$ Mn) Analysis, 2013–2017
Figure 59 : Aus & NZ . Immune Repertoire Sequencing Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 60 : China  Immune Repertoire Sequencing Market Size (US$ Mn) Analysis, 2013–2017
Figure 61 : China Immune Repertoire Sequencing Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 62 : Japan Immune Repertoire Sequencing Market Size (US$ Mn) Analysis, 2013–2017
Figure 63 : Japan Immune Repertoire Sequencing Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 64 : Rest of Asia Pacific Immune Repertoire Sequencing Market Size (US$ Mn) Analysis, 2013–2017
Figure 65 : Rest of Asia Pacific Immune Repertoire Sequencing Market Size (US$ Mn) Analysis, 2013–2017
Figure 66 : Asia Pacific immune repertoire sequencing Detectors Market Attractiveness Analysis, By Component
Figure 67 : Asia Pacific immune repertoire sequencing Detectors Market Attractiveness Analysis, By Application
Figure 68 : Asia Pacific repertoire sequencing Detectors Market Attractiveness Analysis, By End User
Figure 69 : Asia Pacific repertoire sequencing Detectors Market Attractiveness Analysis, By Country
Figure 70 : MEA Immune Repertoire Sequencing Market Size (US$ Mn) Analysis, 2013–2017
Figure 71 : MEA Immune Repertoire Sequencing Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 72 : GCC Countries Immune Repertoire Sequencing Market Size (US$ Mn) Analysis, 2013–2017
Figure 73 : GCC Countries Immune Repertoire Sequencing Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 74 : South Africa Immune Repertoire Sequencing Market Size (US$ Mn) Analysis, 2013–2017
Figure 75 : South Africa Immune Repertoire Sequencing Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 76 : Rest of Middle East & Africa Immune Repertoire Sequencing Market Size (US$ Mn) Analysis, 2013–2017
Figure 77 : Rest of Middle East & Africa Immune Repertoire Sequencing Market Size (US$ Mn) Analysis, 2013–2017
Figure 78 : Middle East & Africa immune repertoire sequencing Detectors Market Attractiveness Analysis, By Component
Figure 79 : Middle East & Africa immune repertoire sequencing Detectors Market Attractiveness Analysis, By Application
Figure 80 : Middle East & Africa immune repertoire sequencing Detectors Market Attractiveness Analysis, By End User
Figure 81 : Middle East & Africa immune repertoire sequencing Detectors Market Attractiveness Analysis, By Country
Figure 82 : Global Immune Repertoire Sequencing Market Share Analysis (%) By Region, 2018 & 2026
Figure 83 : Global Immune Repertoire Sequencing Market Y-o-Y Growth (%) By Region, 2017–2026
Figure 84 : Global Immune Repertoire Sequencing Market Attractiveness Analysis By Region, 2018–2026
Figure 85 : Global  Market Share Analysis (%) By Component, 2018 & 2026
Figure 86 : Global  Market Y-o-Y Growth (%) By Component, 2017–2026
Figure 87 : Global  Market Attractiveness Analysis Component, 2018–2026
Figure 88 : Global  Market Share Analysis (%) By Application , 2018 & 2026
Figure 89 : Global  Market Y-o-Y Growth (%) By Application, 2017–2026
Figure 90 : Global  Market Attractiveness Analysis By Application, 2018–2026
Figure 91 : Global  Market Share Analysis (%) By End User , 2018 & 2026
Figure 92 : Global  Market Y-o-Y Growth (%) By End User, 2017–2026
Figure 93 : Global  Market Attractiveness Analysis By End User, 2018–2026
Figure 94 : Global Immune Repertoire Sequencing Market Value Analysis and Forecast, 2017–2026 (US$ Mn)
Figure 95 : Global Immune Repertoire Sequencing Market Absolute $ Opportunity (US$ Mn), 2017–2026

Immune Repertoire Sequencing Market - Table of Content

Back To Top